246 related articles for article (PubMed ID: 53279)
1. Technetium-99m labeling by means of stannous pyrophosphate: application to bleomycin and red blood cells.
Bardy A; Douyé H; Gobin R; Beydon J; de Tovar G; Pannecière C; Hégésippe M
J Nucl Med; 1975 May; 16(5):435-7. PubMed ID: 53279
[TBL] [Abstract][Full Text] [Related]
2. In vitro technetium-99m red blood cell labeling using commercial stannous pyrophosphate.
Zimmer AM
Am J Hosp Pharm; 1977 Mar; 34(3):264-7. PubMed ID: 857670
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of in vivo labeling of red blood cells with 99mTc.
Colombetti LG; Siddiqui A
Nuklearmedizin; 1976 Oct; 15(5):211-3. PubMed ID: 1005126
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m labeling of red blood cells: in vitro evaluation of a new approach.
Kelbaek H
J Nucl Med; 1986 Nov; 27(11):1770-3. PubMed ID: 3772511
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of labeling procedures and in vivo stability of 99mTc-red blood cells.
Ryo UY; Mohammadzadeh AA; Siddiqui A; Colombetti LG; Pinsky SM
J Nucl Med; 1976 Feb; 17(02):133-6. PubMed ID: 1245875
[TBL] [Abstract][Full Text] [Related]
6. In vivo labeling of red blood cells with Tc-99m with stannous pyridoxylideneaminates.
Kato M
J Nucl Med; 1979 Oct; 20(10):1071-4. PubMed ID: 536758
[TBL] [Abstract][Full Text] [Related]
7. Stoichiometric Tc-99m RBC labeling using stable kit solutions of stannous chloride and EDTA: concise communication.
Mock BH; Wellman HN
J Nucl Med; 1984 Aug; 25(8):881-6. PubMed ID: 6431061
[TBL] [Abstract][Full Text] [Related]
8. A comparative evaluation of techniques for rapid and efficient in vivo labeling of red cells with [99mTc] pertechnetate.
Hamilton RG; Alderson PO
J Nucl Med; 1977 Oct; 18(10):1010-3. PubMed ID: 903468
[TBL] [Abstract][Full Text] [Related]
9. Effect of Sn(II) ion concentration and heparin on technetium-99m red blood cell labeling.
Rao SA; Knobel J; Collier BD; Isitman AT
J Nucl Med; 1986 Jul; 27(7):1202-6. PubMed ID: 3014088
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte labeling with technetium-99m tin colloids.
Mock BH; English D
J Nucl Med; 1987 Sep; 28(9):1471-7. PubMed ID: 3625299
[TBL] [Abstract][Full Text] [Related]
11. In vivo labeling of red blood cells with 99mTc: a new approach to blood pool visualization.
Pavel DG; Zimmer M; Patterson VN
J Nucl Med; 1977 Mar; 18(3):305-8. PubMed ID: 839281
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticals.
Fritzberg AR; Lyster DM; Dolphin DH
J Nucl Med; 1977 Jun; 18(6):553-7. PubMed ID: 192859
[TBL] [Abstract][Full Text] [Related]
13. Technical parameters of in vivo red blood cell labeling with Technetium-99m.
Zimmer AM; Pavel DG; Karesh SM
Nuklearmedizin; 1979 Dec; 18(5):241-5. PubMed ID: 547251
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m radiopharmaceutical preparation by surface adsorbed stannous ions.
Salehi N; Lichtenstein M; Pojer PM
J Nucl Med; 1987 Jun; 28(6):1041-6. PubMed ID: 3675734
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic aspects of the interaction of 99mTc in association with stannous pyrophosphate with damaged red blood cells.
Billinghurst MW; Waddell TL
Int J Appl Radiat Isot; 1983 Mar; 34(3):607-12. PubMed ID: 6303965
[TBL] [Abstract][Full Text] [Related]
16. Labeling of red blood cells with Tc-99m after oral administration of SnCl2: concise communication.
Patel MC; Parab PB; Samuel AM; Ganatra RD
J Nucl Med; 1979 Aug; 20(8):877-81. PubMed ID: 541736
[TBL] [Abstract][Full Text] [Related]
17. A new stannous agent kit for labelling red blood cells with 99TCM and its clinical application.
Ducassou D; Arnaud D; Bardy A; Beydon J; Baquey C
Br J Radiol; 1976 Apr; 49(580):344-7. PubMed ID: 181112
[TBL] [Abstract][Full Text] [Related]
18. Influence of tobacco on the labelling of red blood cells and plasma proteins with technetium-99m.
Vidal MV; Gutfilen B; da Fonseca LM; Bernardo-Filho M
J Exp Clin Cancer Res; 1998 Mar; 17(1):41-6. PubMed ID: 9646232
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m labeling of polymorphonuclear leukocytes: preparation with two different stannous agents.
Kelbaek H; Fogh J
J Nucl Med; 1985 Jan; 26(1):68-71. PubMed ID: 3965654
[TBL] [Abstract][Full Text] [Related]
20. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
Kowalsky RJ; Dalton DR
Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
